Penumbra Announces Pricing Of Offering Of 1,300,000 Shares Of Its Common Stock Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing May 30, 2017 Gene Therapy Firm Files for $35 Million IPO August 21, 2017 71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing May 30, 2017
71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017